Authors: Kerawala, M Ambler, JE Lee, PYC Drabu, YJ

Citation: M. Kerawala et al., In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae, EUR J CL M, 20(4), 2001, pp. 271-275

Authors: Ambler, JE Kerawala, M Yaneza, A Drabu, YJ

Citation: Je. Ambler et al., Evaluation of CHROMagar candida for rapid identification and Etest for antifungal susceptibility testing in a district general hospital laboratory, J CLIN PATH, 54(2), 2001, pp. 158-159

Authors: Heaton, VJ Ambler, JE Fisher, LM

Citation: Vj. Heaton et al., Potent antipneumococcal activity of gemifloxacin is associated with dual targeting of gyrase and topoisomerase IV, an in vivo target preference for gyrase, and enhanced stabilization of cleavable complexes in vitro, ANTIM AG CH, 44(11), 2000, pp. 3112-3117

Authors: Heaton, VJ Goldsmith, CE Ambler, JE Fisher, LM

Citation: Vj. Heaton et al., Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms, ANTIM AG CH, 43(12), 1999, pp. 2998-3000